These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 18255292)
1. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-N,N-dialkyluronamides as human A3 adenosine receptor antagonists. Jeong LS; Lee HW; Kim HO; Tosh DK; Pal S; Choi WJ; Gao ZG; Patel AR; Williams W; Jacobson KA; Kim HD Bioorg Med Chem Lett; 2008 Mar; 18(5):1612-6. PubMed ID: 18255292 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of 2-chloro-N6-substituted-4'-thioadenosine-5'-N, N-dialkyluronamides as potent and selective A3 adenosine receptor antagonists. Choi WJ; Lee HW; Hou X; Kim HO; Jacobson KA; Jeong LS Nucleic Acids Symp Ser (Oxf); 2008; (52):645-6. PubMed ID: 18776545 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptor. Jeong LS; Lee HW; Jacobson KA; Kim HO; Shin DH; Lee JA; Gao ZG; Lu C; Duong HT; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR J Med Chem; 2006 Jan; 49(1):273-81. PubMed ID: 16392812 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists. Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists. Choi WJ; Lee HW; Kim HO; Chinn M; Gao ZG; Patel A; Jacobson KA; Moon HR; Jung YH; Jeong LS Bioorg Med Chem; 2009 Dec; 17(23):8003-11. PubMed ID: 19879151 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists. Jeong LS; Pal S; Choe SA; Choi WJ; Jacobson KA; Gao ZG; Klutz AM; Hou X; Kim HO; Lee HW; Lee SK; Tosh DK; Moon HR J Med Chem; 2008 Oct; 51(20):6609-13. PubMed ID: 18811138 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of truncated 4'-thioadenosine derivatives as potent and selective A3 adenosine receptor antagonists. Hou X; Pal S; Choi WJ; Kim HO; Tipnis A; Jacobson KA; Jeong LS Nucleic Acids Symp Ser (Oxf); 2008; (52):641-2. PubMed ID: 18776543 [TBL] [Abstract][Full Text] [Related]
8. Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety. Gao ZG; Joshi BV; Klutz AM; Kim SK; Lee HW; Kim HO; Jeong LS; Jacobson KA Bioorg Med Chem Lett; 2006 Feb; 16(3):596-601. PubMed ID: 16289820 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptor. Jeong LS; Lee HW; Kim HO; Jung JY; Gao ZG; Duong HT; Rao S; Jacobson KA; Shin DH; Lee JA; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR Bioorg Med Chem; 2006 Jul; 14(14):4718-30. PubMed ID: 16603368 [TBL] [Abstract][Full Text] [Related]
10. Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists. Jeong LS; Choe SA; Gunaga P; Kim HO; Lee HW; Lee SK; Tosh DK; Patel A; Palaniappan KK; Gao ZG; Jacobson KA; Moon HR J Med Chem; 2007 Jul; 50(14):3159-62. PubMed ID: 17555308 [TBL] [Abstract][Full Text] [Related]
11. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists. Tchilibon S; Joshi BV; Kim SK; Duong HT; Gao ZG; Jacobson KA J Med Chem; 2005 Mar; 48(6):1745-58. PubMed ID: 15771421 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-alkynyl substituted 4'-thioadenosine derivatives and their binding affinities at the adenosine receptors. Liang CW; Choi WJ; Jeong LS Arch Pharm Res; 2008 Aug; 31(8):973-7. PubMed ID: 18787783 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists. Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989 [TBL] [Abstract][Full Text] [Related]
14. Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system. Melman A; Wang B; Joshi BV; Gao ZG; Castro Sd; Heller CL; Kim SK; Jeong LS; Jacobson KA Bioorg Med Chem; 2008 Sep; 16(18):8546-56. PubMed ID: 18752961 [TBL] [Abstract][Full Text] [Related]
15. "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists. Perreira M; Jiang JK; Klutz AM; Gao ZG; Shainberg A; Lu C; Thomas CJ; Jacobson KA J Med Chem; 2005 Jul; 48(15):4910-8. PubMed ID: 16033270 [TBL] [Abstract][Full Text] [Related]
16. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists. Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777 [TBL] [Abstract][Full Text] [Related]
17. Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety. Gao ZG; Jeong LS; Moon HR; Kim HO; Choi WJ; Shin DH; Elhalem E; Comin MJ; Melman N; Mamedova L; Gross AS; Rodriguez JB; Jacobson KA Biochem Pharmacol; 2004 Mar; 67(5):893-901. PubMed ID: 15104242 [TBL] [Abstract][Full Text] [Related]
18. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists. Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637 [TBL] [Abstract][Full Text] [Related]
19. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives. Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685 [TBL] [Abstract][Full Text] [Related]
20. Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors. Baraldi PG; Cacciari B; Spalluto G; Ji XD; Olah ME; Stiles G; Dionisotti S; Zocchi C; Ongini E; Jacobson KA J Med Chem; 1996 Feb; 39(3):802-6. PubMed ID: 8576924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]